Ahmed A E Mourad

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Molecular Docking

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mai A E Mourad, Ayman Abo Elmaaty, Islam Zaki, Ahmed A E Mourad, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Ahmed Elkamhawy, Eun Joo Roh, Ahmed Ali Al-Karmalawy
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2- a ]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Esam M Aboubakr, Ahmed R N Ibrahim, Fares E M Ali, Ahmed A E Mourad, Adel M Ahmad, Amal Hofni
Fasudil Ameliorates Methotrexate-Induced Hepatotoxicity by Modulation of Redox-Sensitive Signals. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Ahmed A E Mourad, Ahmed E Khodir, Sameh Saber, Mai A E Mourad
Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Sameh Saber, Eslam E Saad, Galal Yahya, Naglaa A Gobba, Abdalkareem Omar Maghmomeh, Ahmed E Khodir, Ahmed A E Mourad, Ahmed S Saad, Hager G Mohammed, Nehal A Nouh, Ahmed Shata, Noha A Amin, Magdy Abou El-Rous, Samuel Girgis, Eman El-Ahwany, Eman M Khalaf, Attalla Farag El-Kott, Ahmed M El-Baz
A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)